FIGURE 2.
Duration of doxorubicin treatment by mode of doxorubicin administration, unadjusted analysis. (A) (top): Primary analysis ignoring gap periods. (B) (bottom): Sensitivity analysis up to the first 90‐day gap.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.